Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Lilly noted in a press release that at 80 weeks, all the doses of retatrutide met the primary and key secondary endpoints for obesity, delivering clinically meaningful weight loss. TRIUMPH-1 highlights the importance of options and the potential for retatrutide to help people across various stages of their obesity journey, Kenneth Custer, PhD, executive vice president and president, Lilly Cardiometabolic Health, said in a press release
Furthermore, GLP-1 weight loss medication is believed to influence metabolism in various ways, such as improving fat breakdown or reducing fat accumulation
Nearctic living in the Nearctic biogeographic province, the northern part of the New World
A major concern people have when starting GLP-1 medications is that most of the weight lost will be muscle mass
